Victor Rakesh Lazar1, Gary P. Liney2, David J. Manton1, Peter Gibbs1, Martin Lowry1, Celia L. Gregson3, Joern Rittweger4, Sue Steel5, Chris Langton6, J H. Tobias3, Lindsay W. Turnbull1
1Centre for MR Investigations, University of Hull, Hull, North Humberside, United Kingdom; 2Radiotherapy Physics, University of Hull, Hull, North Humberside, United Kingdom; 3Academic Rheumatology, University of Bristol, Bristol, United Kingdom; 4Excercise and Sports Medicine, Manchester Metropolitan University, Manchester, United Kingdom; 5Centre for Metabolic Bone Disease, Hull Royal Infirmary, Hull, United Kingdom; 6School of Physical and Chemical Sciences, Queensland University of Technology, Australia
Peripheral Quantitative Computed Tomography (pQCT) and Dual Energy X-Ray Absorptiometry (DEXA) are the current gold standards for the measurement of bone density and structure, in the research and clinical setting respectively. However, Magnetic Resonance Imaging (MRI) and unsuppressed 1H Magnetic Resonance Spectroscopy (MRS) can also offer several advantages including the ability to quantify bone marrow content and structure. In-house software was developed to process and evaluate cortical and trabecular bone structure, marrow composition and vertebrae segmentation using data from MRI/MRS and structural details from pQCT.